These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33270801)

  • 21. Association of Pregnancy and HIV Status With Molecular-Bacterial Vaginosis in Indian Women.
    Tuddenham S; Shafiq M; Mathad JS; Alexander M; Naik S; Kulkarni V; Deshpande P; Humphrys MS; Holm JB; Khan N; Yadana S; Cheedalla A; Bhosale R; Ghanem KG; Wang T; Wang S; Ma B; Ravel J; Gupta A; Shivakoti R
    J Acquir Immune Defic Syndr; 2023 Aug; 93(5):422-430. PubMed ID: 37155962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 16S rRNA female reproductive microbiome investigation reveals Dalfopristin, Clorgyline, and Hydrazine as potential therapeutics for the treatment of bacterial vaginosis.
    Kulshrestha S; Redhu R; Dua R; Gupta R; Gupta P; Gupta S; Narad P; Sengupta A
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116349. PubMed ID: 38744093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-exposure prophylaxis and antiretroviral treatment interventions with drug resistance.
    Afassinou K; Chirove F; Govinder KS
    Math Biosci; 2017 Mar; 285():92-101. PubMed ID: 28095307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The cervicovaginal mucus barrier to HIV-1 is diminished in bacterial vaginosis.
    Hoang T; Toler E; DeLong K; Mafunda NA; Bloom SM; Zierden HC; Moench TR; Coleman JS; Hanes J; Kwon DS; Lai SK; Cone RA; Ensign LM
    PLoS Pathog; 2020 Jan; 16(1):e1008236. PubMed ID: 31971984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Female genital-tract HIV load correlates inversely with Lactobacillus species but positively with bacterial vaginosis and Mycoplasma hominis.
    Sha BE; Zariffard MR; Wang QJ; Chen HY; Bremer J; Cohen MH; Spear GT
    J Infect Dis; 2005 Jan; 191(1):25-32. PubMed ID: 15592999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Evolving Facets of Bacterial Vaginosis: Implications for HIV Transmission.
    McKinnon LR; Achilles SL; Bradshaw CS; Burgener A; Crucitti T; Fredricks DN; Jaspan HB; Kaul R; Kaushic C; Klatt N; Kwon DS; Marrazzo JM; Masson L; McClelland RS; Ravel J; van de Wijgert JHHM; Vodstrcil LA; Tachedjian G
    AIDS Res Hum Retroviruses; 2019 Mar; 35(3):219-228. PubMed ID: 30638028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promising Prebiotic Candidate Established by Evaluation of Lactitol, Lactulose, Raffinose, and Oligofructose for Maintenance of a Lactobacillus-Dominated Vaginal Microbiota.
    Collins SL; McMillan A; Seney S; van der Veer C; Kort R; Sumarah MW; Reid G
    Appl Environ Microbiol; 2018 Mar; 84(5):. PubMed ID: 29269494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis.
    Borgdorff H; Armstrong SD; Tytgat HL; Xia D; Ndayisaba GF; Wastling JM; van de Wijgert JH
    PLoS One; 2016; 11(3):e0150767. PubMed ID: 26963809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the vaginal microbiome as a potential strategy to reduce heterosexual HIV transmission.
    Armstrong E; Kaul R; Cohen CR
    J Intern Med; 2023 Apr; 293(4):433-444. PubMed ID: 36544257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of Vaginal Microbiome by Nitric Oxide.
    Yeruva T; Lee CH
    Curr Pharm Biotechnol; 2019; 20(1):17-31. PubMed ID: 30727888
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women.
    Klatt NR; Cheu R; Birse K; Zevin AS; Perner M; Noël-Romas L; Grobler A; Westmacott G; Xie IY; Butler J; Mansoor L; McKinnon LR; Passmore JS; Abdool Karim Q; Abdool Karim SS; Burgener AD
    Science; 2017 Jun; 356(6341):938-945. PubMed ID: 28572388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of fastidious vaginal bacteria in women with HIV infection and bacterial vaginosis.
    Mitchell C; Moreira C; Fredricks D; Paul K; Caliendo AM; Kurpewski J; Ingersoll J; Cu-Uvin S
    Infect Dis Obstet Gynecol; 2009; 2009():236919. PubMed ID: 19920869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The future of pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) infection.
    Özdener AE; Park TE; Kalabalik J; Gupta R
    Expert Rev Anti Infect Ther; 2017 May; 15(5):467-481. PubMed ID: 28322067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that the endometrial microbiota has an effect on implantation success or failure.
    Moreno I; Codoñer FM; Vilella F; Valbuena D; Martinez-Blanch JF; Jimenez-Almazán J; Alonso R; Alamá P; Remohí J; Pellicer A; Ramon D; Simon C
    Am J Obstet Gynecol; 2016 Dec; 215(6):684-703. PubMed ID: 27717732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacterial vaginosis, human papilloma virus and herpes viridae do not predict vaginal HIV RNA shedding in women living with HIV in Denmark.
    Wessman M; Thorsteinsson K; Jensen JS; Storgaard M; Rönsholt FF; Johansen IS; Pedersen G; Nørregård Nielsen L; Bonde J; Katzenstein TL; Weis N; Lebech AM
    BMC Infect Dis; 2017 May; 17(1):376. PubMed ID: 28569142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The global health impact of vaginal dysbiosis.
    van de Wijgert JHHM; Jespers V
    Res Microbiol; 2017; 168(9-10):859-864. PubMed ID: 28257809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis.
    Zozaya M; Ferris MJ; Siren JD; Lillis R; Myers L; Nsuami MJ; Eren AM; Brown J; Taylor CM; Martin DH
    Microbiome; 2016 Apr; 4():16. PubMed ID: 27090518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
    Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L;
    Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    Mugwanya KK; Hendrix CW; Mugo NR; Marzinke M; Katabira ET; Ngure K; Semiyaga NB; John-Stewart G; Muwonge TR; Muthuri G; Stergachis A; Celum CL; Baeten JM
    PLoS Med; 2016 Sep; 13(9):e1002132. PubMed ID: 27676257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Periodic Presumptive Treatment for Bacterial Vaginosis on the Vaginal Microbiome among Women Participating in the Preventing Vaginal Infections Trial.
    Balkus JE; Srinivasan S; Anzala O; Kimani J; Andac C; Schwebke J; Fredricks DN; McClelland RS
    J Infect Dis; 2017 Mar; 215(5):723-731. PubMed ID: 28007924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.